CKD Bio Corp. (063160.KS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

26.0x

Market Cap

KRW 74.61B

MomentumView details →

1D Return

−0.95%

YTD Return

−32.97%

RSI (14)

46.2

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

26.0x

Market Cap

KRW 74.61B

RSI (14)

46.2

MomentumView details →

1D Return

−0.95%

YTD Return

−32.97%

ProfitabilityView details →

Gross Margin

8.61%

Net Margin

−6.79%

EBITDA Margin

5.40%

ROE (TTM)

−8.98%

ROA (TTM)

−3.67%

Asset Turnover

0.53x

GrowthView details →

Revenue YoY

−0.58%

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

+0.85%

EPS CAGR 3Y

—

EBITDA YoY

−46.81%

EarningsView details →

EPS (Actual)

−KRW 985.24

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

KRW 0.00

Avg Surprise (4Q)

—

Rev Surprise

−8.29%

Capital & dividendView details →

Debt/Equity

1.24x

Current Ratio

1.06x

Quick Ratio

0.33x

Div Yield

—

Div Rate

—

Div Growth 1Y

+0.00%

Financials snapshotView financials →

Revenue (TTM)

158.12B

Net Income (TTM)

−10.74B

Op. CF (TTM)

1.01B

Latest newsMore news →

No recent news for 063160.KS.

Similar companies

Huons Global Co., Ltd.084110.KQ Ildong Holdings Co., Ltd.000230.KS Kukje Pharma Co., Ltd.002720.KS Enzychem Lifesciences Corporation183490.KQ Yuyu Pharma, Inc.000220.KS 复星医药600196.SH Find similar companies →

Latest newsMore news →

No recent news for 063160.KS.